Daniel Trencher - 11 Oct 2021 Form 4 Insider Report for Teladoc Health, Inc. (TDOC)

Role
SVP Corporate Strategy
Signature
/s/ Adam C. Vandervoort, attorney-in-fact
Issuer symbol
TDOC
Transactions as of
11 Oct 2021
Transactions value $
-$217,520
Form type
4
Filing time
12 Oct 2021, 16:10:45 UTC
Previous filing
13 Sep 2021
Next filing
12 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TDOC Common Stock Options Exercise $44,600 +2,000 +8.5% $22.3 25,486 11 Oct 2021 Direct F1
transaction TDOC Common Stock Sale -$262,120 -2,000 -7.8% $131.06 23,486 11 Oct 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TDOC Employee Stock Option (right to buy) Options Exercise $0 -2,000 -9.3% $0 19,430 11 Oct 2021 Common Stock 2,000 $22.3 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on February 28, 2020.
F2 The option vested as to 25% of the shares on March 3, 2018. The remainder of the shares vested in 36 equal monthly installments thereafter.